Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-02-23

FDA Approved: ATOMOXETINE — Original Application (Dr. Reddy's Laboratories Limited)

View source ↗

Summary

FDA approved an original ANDA for atomoxetine, a non-stimulant medication used to treat attention-deficit/hyperactivity disorder, with Dr. Reddy's Laboratories …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atomoxetine (Atomoxetine)

Snippet

ORIG AP for ATOMOXETINE (ATOMOXETINE)